Dietary Polyphenols in Metabolic Diseases: Roles of Gut Microbiota‐Derived Metabolites
Phytotherapy Research · 2026
DOI: 10.1002/ptr.70180 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2026. Written by Pengzhao Tang and 6 co-authors. Institution: Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University of Trad…. Major MEDLINE topics: Polyphenols, Metabolic Diseases, Gastrointestinal Microbiome. Cited 3 times so far (Crossref); 311 references. Funded by: National Natural Science Foundation of China, Sichuan Science and Technology Program, Sichuan Provincial Administration of Traditional Chinese Medicine.
Abstract (original language)
Metabolic diseases are a series of chronic diseases accompanied by the body's substance and energy metabolism disorders. Due to their high prevalence rate, metabolic diseases have become a global public health challenge. The effect of polyphenols on gut microbiota‐derived metabolites is considered one of the main mechanisms through which they exert their benefits on metabolic diseases. However, comprehensive summarization of the interactions between polyphenols and metabolic diseases is still lacking, especially from the perspective of gut microbiota‐derived metabolites. In this review, we first discussed the effects of polyphenols on gut microbiota‐derived metabolites and relevant mechanisms. Polyphenols affect these metabolites by regulating gut microbiota composition, impacting enzymes, receptors, and transporters. Then, categorized by the different metabolic diseases, including obesity, atherosclerosis, type 2 diabetes mellitus, non‐alcoholic fatty liver disease, gout, and osteoporosis, we summarized the corresponding polyphenols‐modulated gut microbiota‐derived metabolites in each metabolic disease and the role of these metabolites in the treatment of metabolic diseases. In addition, we also provided our suggestions for future research on polyphenols. Our review provided a reasonable reference for the better utilization of polyphenols.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Key Laboratory of the Ministry of Education for Standardization of Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Funding
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Sichuan Provincial Administration of Traditional Chinese Medicine
Cite
APA
Tang, P., Feng, H., Zhang, D., Wu, J., Zhou, Y., Feng, W., & Peng, C. (2026). Dietary Polyphenols in Metabolic Diseases: Roles of Gut Microbiota‐Derived Metabolites. Phytotherapy Research. https://doi.org/10.1002/ptr.70180
Vancouver
Tang P, Feng H, Zhang D, Wu J, Zhou Y, Feng W, et al. Dietary Polyphenols in Metabolic Diseases: Roles of Gut Microbiota‐Derived Metabolites. Phytotherapy Research. 2026. doi:10.1002/ptr.70180
BibTeX
@article{Tang2026,
author = {Tang, Pengzhao and Feng, Hui and Zhang, Dandan and Wu, Jinlu and Zhou, Yaochuan and Feng, Wuwen and Peng, Cheng},
title = {Dietary Polyphenols in Metabolic Diseases: Roles of Gut Microbiota‐Derived Metabolites},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70180}
}
EUVIMED